Effectiveness of a Laboratory Gate-Keeping Strategy to Overcome Inappropriate Test Utilization for the Diagnosis of Heparin-Induced Thrombocytopenia

Janne Cadamuro; Cornelia Mrazek; Helmut Wiedemann; Thomas Klaus Felder; Hannes Oberkofler; Elisabeth Haschke-Becher; Giuseppe Lippi

doi:10.1055/s-0037-1604054

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2017; 43(06): 645-648
DOI: 10.1055/s-0037-1604054

Letter to the Editor

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Effectiveness of a Laboratory Gate-Keeping Strategy to Overcome Inappropriate Test Utilization for the Diagnosis of Heparin-Induced Thrombocytopenia

Janne Cadamuro

¹Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria

,

Cornelia Mrazek

¹Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria

,

Helmut Wiedemann

¹Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria

,

Thomas Klaus Felder

¹Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria

,

Hannes Oberkofler

¹Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria

,

Elisabeth Haschke-Becher

¹Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria

,

Giuseppe Lippi

²Section of Clinical Biochemistry, University Hospital of Verona, Verona, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Carter R. Report of the Second Phase of the Independent Review of NHS Pathology Services in England. United Kingdom: Department of Health; 2008
2 Studdert DM, Mello MM, Sage WM. , et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA 2005; 293 (21) 2609-2617
3 Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One 2013; 8 (11) e78962
4 The World Bank Group. Health expenditure. Available at: http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS . Accessed April 21, 2017
5 European Diagnostic Manufacturers Association (EDMA). European IVD Market Statistics Report 2011–2015
6 Freedman DB. Towards better test utilization–strategies to improve physician ordering and their impact on patient outcomes. EJIFCC 2015; 26 (01) 15-30
7 Wertheim BM, Aguirre AJ, Bhattacharyya RP. , et al. An educational and administrative intervention to promote rational laboratory test ordering on an academic general medicine service. Am J Med 2017; 130 (01) 47-53
8 Hoffmann GE, Aufenanger J, Födinger M. , et al. Benefits and limitations of laboratory diagnostic pathways. Diagnosis 2014; 1 (04) 269-276
9 Lang T, Croal B. National minimum retesting intervals in pathology. London: The Royal College of Pathologists; 2015. . Contract no: G147
10 Prechel M, Walenga JM. Heparin-induced thrombocytopenia: an update. Semin Thromb Hemost 2012; 38 (05) 483-496
11 Berroëta C, Crespin M, Bouabdallah K. , et al. Diagnostic performance of a new rapid lateral flow immunoassay in patients suspected of heparin-induced thrombocytopenia and its clinical consequences. Semin Thromb Hemost 2016; 42 (01) 69-74
12 Greinacher A. CLINICAL PRACTICE. Heparin-induced thrombocytopenia. N Engl J Med 2015; 373 (03) 252-261
13 Favaloro EJ, McCaughan G, Pasalic L. Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update. Pathology 2017; 49 (04) 346-355
14 Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost 2015; 41 (01) 49-60
15 Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 2012; 120 (20) 4160-4167
16 Favaloro EJ. Toward improved diagnosis of HIT. Blood 2015; 126 (05) 563-564